Detailed Information on Publication Record
2012
Malleability and Versatility of Cytochrome P450 Active Sites Studied by Molecular Simulations
OOSTENBRINK, Chris, Anita DE RUITER, Jozef HRITZ and Nico VERMEULENBasic information
Original name
Malleability and Versatility of Cytochrome P450 Active Sites Studied by Molecular Simulations
Authors
OOSTENBRINK, Chris, Anita DE RUITER, Jozef HRITZ and Nico VERMEULEN
Edition
CURRENT DRUG METABOLISM, SHARJAH, BENTHAM SCIENCE PUBL LTD, 2012, 1389-2002
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
Genetics and molecular biology
Country of publisher
United Arab Emirates
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 4.405
Organization unit
Central European Institute of Technology
UT WoS
000300417500007
Keywords in English
Site of metabolism prediction; protein flexibility; molecular docking; molecular dynamics simulations; replica exchange
Tags
Tags
International impact, Reviewed
Změněno: 25/2/2014 12:56, Olga Křížová
Abstract
V originále
As the most important phase I drug metabolizing enzymes, the human Cytochromes P450 display an enormous versatility in the molecular structures of possible substrates. Individual isoforms may preferentially bind specific classes of molecules, but also within these classes, some isoforms show remarkable levels of promiscuity. In this work, we try to link this promiscuity to the versatility and malleability of the active site at the hand of examples from our own work. Mainly focusing on the flexibility of protein structures and the presence or absence of water molecules, we establish molecular reasons for observed promiscuity, determine the relevant factors to take into account when predicting binding poses and rationalize the role of individual interactions in the process of ligand binding. A high level of active site flexibility does not only allow for the binding of a large variety of substrates and inhibitors, but also appears to be important to facilitate ligand binding and unbinding.